CN104491001A - Traditional Chinese medicine composition for treating osteoporosis - Google Patents
Traditional Chinese medicine composition for treating osteoporosis Download PDFInfo
- Publication number
- CN104491001A CN104491001A CN201410732178.5A CN201410732178A CN104491001A CN 104491001 A CN104491001 A CN 104491001A CN 201410732178 A CN201410732178 A CN 201410732178A CN 104491001 A CN104491001 A CN 104491001A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicine
- traditional chinese
- medicine composition
- nourishing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating osteoporosis. The traditional Chinese medicine composition consists of the following traditional Chinese medicines: 12g to18g of the bark of eucommia, 12g to 18g of the root of red-rooted salvia, 12g to 18g of astragalus membranaceus, 8g to 12g of herba epimedii, 8g to 12g of fructus psoraleae, 8g to 12g of pulp of dogwood fruit and 8g to 12g of the pulp of walnut. The traditional Chinese medicine composition is formed by adding or reducing components into an ancient prescription of a qing-er pill and has the main effects of nourishing kidney to enhance the sexual function. In the prescription, the bark of the eucommia is used as a monarch drug and has the effects of nourishing kidney to enhance the sexual function and strengthening tendons and bones; the herba epimedii is used as a ministerial drug and has the effects of dispelling wind, removing dampness, nourishing bone fat, warming meridians to stop diarrhea and arresting spontaneous emission and leukorrhagia; as the ministerial drugs, the two medicines can be combined in use to help the monarch drug to nourish the kidney to enhance the sexual function; the pulp of the walnut and the pulp of the dogwood fruit are used as adjuvant drugs and are combined in use to play the effects of nourishing liver and kidney, strengthening waist and knees, wetting joint holes and nourishing marrow; the red-rooted salvia has the effects of promoting blood circulation to remove stasis, clearing heat, cooling blood, nourishing blood and soothing nerves; the astragalus membranaceus is sweet and tepor and acts on lung and spleen channels; and as the conductant drugs, the red-rooted salvia and the astragalus membranaceus are combined in use to play the effects of replenishing qi, nourishing blood and promoting the flowing of qi to remove the stasis. In the traditional Chinese medicine composition disclosed by the invention, each traditional Chinese medicine has a medicinal effect; and by simultaneous application of all the traditional Chinese medicines, the function of the body can be regulated in a balanced manner, so that the aim of treating the osteoporosis can be realized.
Description
Technical field
The present invention relates to Chinese medicine composition, especially one is used for the treatment of osteoporotic Chinese medicine composition.
Background technology
Osteoporosis is one group of osteopathia that many reasons causes, and osseous tissue has normal calcification, and calcium salt and substrate are normal rates, and the metabolic osteopathy being reduced to feature with unit volume inner bone tissues amount becomes.In most osteoporosis, caused by the minimizing of osseous tissue increases mainly due to bone absorption.With skeleton pain, be easy to fracture for feature.
Summary of the invention
Technical problem to be solved by this invention is to provide one and is used for the treatment of osteoporotic Chinese medicine composition, can effectively treat osteoporotic disease.
For solving the problems of the technologies described above, technical scheme of the present invention is: one is used for the treatment of osteoporotic Chinese medicine composition, be made up of following Chinese medicine: the Cortex Eucommiae 12 ~ 18 grams, Radix Salviae Miltiorrhizae 12 ~ 18 grams, the Radix Astragali 12 ~ 18 grams, Herba Epimedii 8 ~ 12 grams, Fructus Psoraleae 8 ~ 12 grams, Fructus Corni 8 ~ 12 grams, Semen Juglandis 8 ~ 12 grams.The present invention, by ancient prescription Qing-er pill addition or subtraction of changes, focuses on kidney invigorating and YANG supporting.Cortex Eucommiae kidney invigorating and YANG supporting in side, bone and muscle strengthening is monarch drug; Herba Epimedii is held concurrently expelling wind and removing dampness, and Fructus Psoraleae is held concurrently warming the meridian antidiarrheal, controlling nocturnal emission with astringent drugs contracting spring, and two medicines share principal drug assistance kidney invigorating and YANG supporting, are ministerial drug; Semen Juglandis, Fructus Corni share invigorating the liver and kidney, strong waist knee joint, and profit closes key, and beneficial marrow is adjuvant drug; Radix Salviae Miltiorrhizae function blood circulation promoting and blood stasis dispelling, clearing away heat and cooling blood, nourishing blood to tranquillize the mind, the Radix Astragali is sweet, tepor, people's lung, spleen channel, and two medicines share benefiting qi and nourishing blood, regulating qi to disperse stagnation, for making medicine.The present invention often plants the drug effect that Chinese medicine has self, uses simultaneously and more can carry out balance conditioning to each function of health, to reach the osteoporotic object for the treatment of.
As improvement, described Chinese medicine composition is made up of following Chinese medicine: the Cortex Eucommiae 12 grams, Radix Salviae Miltiorrhizae 12 grams, the Radix Astragali 12 grams, Herba Epimedii 8 grams, Fructus Psoraleae 8 grams, Fructus Corni 8 grams, Semen Juglandis 8 grams.
As improvement, described Chinese medicine composition is made up of following Chinese medicine: the Cortex Eucommiae 15 grams, Radix Salviae Miltiorrhizae 15 grams, the Radix Astragali 15 grams, Herba Epimedii 10 grams, Fructus Psoraleae 10 grams, Fructus Corni 10 grams, Semen Juglandis 10 grams.
As improvement, described Chinese medicine composition is made up of following Chinese medicine: the Cortex Eucommiae 18 grams, Radix Salviae Miltiorrhizae 18 grams, the Radix Astragali 18 grams, Herba Epimedii 12 grams, Fructus Psoraleae 12 grams, Fructus Corni 12 grams, Semen Juglandis 12 grams.
The beneficial effect that the present invention is compared with prior art brought is:
The present invention often plants the drug effect that Chinese medicine has self, uses simultaneously and more can carry out balance conditioning to each function of health, to reach the osteoporotic object for the treatment of.
Detailed description of the invention
Embodiment 1
One is used for the treatment of osteoporotic Chinese medicine composition, is made up of following Chinese medicine: the Cortex Eucommiae 12 grams, Radix Salviae Miltiorrhizae 12 grams, the Radix Astragali 12 grams, Herba Epimedii 8 grams, Fructus Psoraleae 8 grams, Fructus Corni 8 grams, Semen Juglandis 8 grams.The present invention, by ancient prescription Qing-er pill addition or subtraction of changes, focuses on kidney invigorating and YANG supporting.Cortex Eucommiae kidney invigorating and YANG supporting in side, bone and muscle strengthening is monarch drug; Herba Epimedii is held concurrently expelling wind and removing dampness, and Fructus Psoraleae is held concurrently warming the meridian antidiarrheal, controlling nocturnal emission with astringent drugs contracting spring, and two medicines share principal drug assistance kidney invigorating and YANG supporting, are ministerial drug; Semen Juglandis, Fructus Corni share invigorating the liver and kidney, strong waist knee joint, and profit closes key, and beneficial marrow is adjuvant drug; Radix Salviae Miltiorrhizae function blood circulation promoting and blood stasis dispelling, clearing away heat and cooling blood, nourishing blood to tranquillize the mind, the Radix Astragali is sweet, tepor, people's lung, spleen channel, and two medicines share benefiting qi and nourishing blood, regulating qi to disperse stagnation, for making medicine.The present invention often plants the drug effect that Chinese medicine has self, uses simultaneously and more can carry out balance conditioning to each function of health, to reach the osteoporotic object for the treatment of.
Embodiment 2
One is used for the treatment of osteoporotic Chinese medicine composition, is made up of following Chinese medicine: the Cortex Eucommiae 15 grams, Radix Salviae Miltiorrhizae 15 grams, the Radix Astragali 15 grams, Herba Epimedii 10 grams, Fructus Psoraleae 10 grams, Fructus Corni 10 grams, Semen Juglandis 10 grams.The present invention, by ancient prescription Qing-er pill addition or subtraction of changes, focuses on kidney invigorating and YANG supporting.Cortex Eucommiae kidney invigorating and YANG supporting in side, bone and muscle strengthening is monarch drug; Herba Epimedii is held concurrently expelling wind and removing dampness, and Fructus Psoraleae is held concurrently warming the meridian antidiarrheal, controlling nocturnal emission with astringent drugs contracting spring, and two medicines share principal drug assistance kidney invigorating and YANG supporting, are ministerial drug; Semen Juglandis, Fructus Corni share invigorating the liver and kidney, strong waist knee joint, and profit closes key, and beneficial marrow is adjuvant drug; Radix Salviae Miltiorrhizae function blood circulation promoting and blood stasis dispelling, clearing away heat and cooling blood, nourishing blood to tranquillize the mind, the Radix Astragali is sweet, tepor, people's lung, spleen channel, and two medicines share benefiting qi and nourishing blood, regulating qi to disperse stagnation, for making medicine.The present invention often plants the drug effect that Chinese medicine has self, uses simultaneously and more can carry out balance conditioning to each function of health, to reach the osteoporotic object for the treatment of.
Embodiment 3
One is used for the treatment of osteoporotic Chinese medicine composition, is made up of following Chinese medicine: the Cortex Eucommiae 18 grams, Radix Salviae Miltiorrhizae 18 grams, the Radix Astragali 18 grams, Herba Epimedii 12 grams, Fructus Psoraleae 12 grams, Fructus Corni 12 grams, Semen Juglandis 12 grams.The present invention, by ancient prescription Qing-er pill addition or subtraction of changes, focuses on kidney invigorating and YANG supporting.Cortex Eucommiae kidney invigorating and YANG supporting in side, bone and muscle strengthening is monarch drug; Herba Epimedii is held concurrently expelling wind and removing dampness, and Fructus Psoraleae is held concurrently warming the meridian antidiarrheal, controlling nocturnal emission with astringent drugs contracting spring, and two medicines share principal drug assistance kidney invigorating and YANG supporting, are ministerial drug; Semen Juglandis, Fructus Corni share invigorating the liver and kidney, strong waist knee joint, and profit closes key, and beneficial marrow is adjuvant drug; Radix Salviae Miltiorrhizae function blood circulation promoting and blood stasis dispelling, clearing away heat and cooling blood, nourishing blood to tranquillize the mind, the Radix Astragali is sweet, tepor, people's lung, spleen channel, and two medicines share benefiting qi and nourishing blood, regulating qi to disperse stagnation, for making medicine.The present invention often plants the drug effect that Chinese medicine has self, uses simultaneously and more can carry out balance conditioning to each function of health, to reach the osteoporotic object for the treatment of.
Claims (4)
1. be used for the treatment of an osteoporotic Chinese medicine composition, it is characterized in that: be made up of following Chinese medicine: the Cortex Eucommiae 12 ~ 18 grams, Radix Salviae Miltiorrhizae 12 ~ 18 grams, the Radix Astragali 12 ~ 18 grams, Herba Epimedii 8 ~ 12 grams, Fructus Psoraleae 8 ~ 12 grams, Fructus Corni 8 ~ 12 grams, Semen Juglandis 8 ~ 12 grams.
2. one according to claim 1 is used for the treatment of osteoporotic Chinese medicine composition, it is characterized in that: described Chinese medicine composition is made up of following Chinese medicine: the Cortex Eucommiae 12 grams, Radix Salviae Miltiorrhizae 12 grams, the Radix Astragali 12 grams, Herba Epimedii 8 grams, Fructus Psoraleae 8 grams, Fructus Corni 8 grams, Semen Juglandis 8 grams.
3. one according to claim 1 is used for the treatment of osteoporotic Chinese medicine composition, it is characterized in that: described Chinese medicine composition is made up of following Chinese medicine: the Cortex Eucommiae 15 grams, Radix Salviae Miltiorrhizae 15 grams, the Radix Astragali 15 grams, Herba Epimedii 10 grams, Fructus Psoraleae 10 grams, Fructus Corni 10 grams, Semen Juglandis 10 grams.
4. one according to claim 1 is used for the treatment of osteoporotic Chinese medicine composition, it is characterized in that: described Chinese medicine composition is made up of following Chinese medicine: the Cortex Eucommiae 18 grams, Radix Salviae Miltiorrhizae 18 grams, the Radix Astragali 18 grams, Herba Epimedii 12 grams, Fructus Psoraleae 12 grams, Fructus Corni 12 grams, Semen Juglandis 12 grams.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410732178.5A CN104491001A (en) | 2014-12-06 | 2014-12-06 | Traditional Chinese medicine composition for treating osteoporosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410732178.5A CN104491001A (en) | 2014-12-06 | 2014-12-06 | Traditional Chinese medicine composition for treating osteoporosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104491001A true CN104491001A (en) | 2015-04-08 |
Family
ID=52932515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410732178.5A Pending CN104491001A (en) | 2014-12-06 | 2014-12-06 | Traditional Chinese medicine composition for treating osteoporosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104491001A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109985221A (en) * | 2018-01-03 | 2019-07-09 | 张来领 | A kind of Chinese medicinal composition for invigorating kidney and strengthening bones and preparation method thereof |
-
2014
- 2014-12-06 CN CN201410732178.5A patent/CN104491001A/en active Pending
Non-Patent Citations (2)
Title |
---|
刘荣奎等主编: "《中医诊断治疗学》", 31 December 2006, 内蒙古科学技术出版社 * |
梁翔等: "彭太平治疗骨质疏松症经验", 《江西中医药》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109985221A (en) * | 2018-01-03 | 2019-07-09 | 张来领 | A kind of Chinese medicinal composition for invigorating kidney and strengthening bones and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101766775A (en) | Medicine for treating lumbar disc herniation and osteoproliferation | |
CN101322789A (en) | Medicinal liquor prescription for treating rheumatism and rheumatoid | |
CN103191383B (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
CN103316141B (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
CN105213747A (en) | Be used for the treatment of osteoporotic ERXIAN TANG | |
CN103800489A (en) | Traditional Chinese medicine wine for treating cervical spondylosis and preparation method of traditional Chinese medicine wine | |
CN100423744C (en) | Medication for treating hyperosteogeny and complicating disease | |
CN105434773A (en) | Kidney-nourishing bone-strengthening soup for treating osteoporosis | |
CN104491001A (en) | Traditional Chinese medicine composition for treating osteoporosis | |
CN103830591A (en) | Traditional Chinese medicine formula for treating stroke and post-traumatic brain syndrome and preparation method of traditional Chinese medicine | |
CN102198208A (en) | Formula of traditional Chinese medicine for treating prolapse of lumbar intervertebral disc | |
CN105079302A (en) | Medicine for treating wind-cold-dampness arthralgia and meridian and collateral obstruction type cervical spondylosis | |
CN104623542A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
CN1460494A (en) | Liquid medicine for external application for making foot therapy | |
CN103301421A (en) | Chinese medicine composition for treating sciatica | |
CN105434654A (en) | Kidney-tonifying and bone-strengthening soup for treating osteoporosis | |
CN105126042A (en) | Medicine composition for treating osteoporosis | |
CN104383205A (en) | Muscle relaxing and blood circulation stimulating medicine liquor externally used for treating orthopedic diseases | |
CN105056127A (en) | Medicine combination for treating heart disease | |
CN105213616A (en) | Be used for the treatment of osteoporotic Cornu Cervi Carapax Et Plastrum Testudinis cream | |
CN103007051B (en) | Traditional Chinese medicine composition for treating heel pain caused by blood stasis | |
CN104740149A (en) | Traditional Chinese medicine foot bath power and preparation and application methods thereof | |
CN104208206A (en) | Medicinal liquor capable of treating rheumatism and ostalgia | |
CN105434655A (en) | Cistanche kidney-invigorating pill for treating osteoporosis | |
CN104606473A (en) | Medicinal liquor capable of nourishing blood and promoting sperm production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |
|
RJ01 | Rejection of invention patent application after publication |